The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
Abstract
Milk thistle (MT;Silybum marianum), a member of the Asteraceae family, is a therapeutic herb with a 2,000‐year history of use. MT fruits contain a mixture of flavonolignans collectively known as silymarin, being silybin (also named silibinin) the main component. This article reviews the chemistry of MT, the pharmacokinetics and bioavailability, the pharmacologically relevant actions for liver diseases (e.g., anti‐inflammatory, immunomodulating, antifibrotic, antioxidant, and liver‐regenerating properties) as well as the clinical potential in patients with alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, drug‐induced liver injury, and mushroom poisoning. Overall, literature data suggest that, despite encouraging preclinical data, further well‐designed randomized clinical trials are needed to fully substantiate the real value of MT preparations in liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,358
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Self-citationHepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan, S. C., & Girish, C. (2006) · PubMed · Cited by 516
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
Ferenci, P., Dragosics, B., Dittrich, H., Frank, H., Benda, L., Lochs, H., Meryn, S., Base, W., & Schneider, B. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90083-4 · Cited by 496
Bijak, M. (2017) · Molecules · doi:10.3390/molecules22111942 · Cited by 414
Araújo, A. R., Rosso, N., Bedogni, G., Tiribelli, C., & Bellentani, S. (2018) · Liver International · doi:10.1111/liv.13643 · Cited by 401
Parés, A., Planas, R., Torres, M., Caballería, J., Viver, J. M., Acero, D., Panés, J., Rigau, J., Santos, J., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80285-7 · Cited by 331
Dimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakellariou, S., Kykalos, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5282 · Cited by 330
Kidd, P. M. (2009) · PubMed · Cited by 304
Loguercio, C., Andreone, P., Brisc, C., Brisc, M. C., Bugianesi, E., Chiaramonte, M., Cursaro, C., Danila, M., de Sio, I., Floreani, A., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.008 · Cited by 267
A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis
Wah Kheong, C., Nik Mustapha, N. R., & Mahadeva, S. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.016 · Cited by 264
Analysis of the active components of silymarin
Kvasnička, F., Bı́ba, B., Ševčı́k, R., Voldřich, M., & Krátká, J. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)01971-4 · Cited by 262
Salomone, F., Godos, J., & Zelber‐Sagi, S. (2016) · Liver International · doi:10.1111/liv.12975 · Cited by 260
Non Alcoholic Fatty Liver: Epidemiology and Natural History
Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., & Persico, M. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216111143 · Cited by 247
Self-citationReassessing bioavailability of silymarin.
Javed, S., Kohli, K., & Ali, M. (2011) · PubMed · Cited by 233
Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., & Perucca, E. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190223 · Cited by 226
An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
Saller, R., Brignoli, R., Melzer, J., & Meier, R. (2008) · Forschende Komplementärmedizin / Research in Complementary Medicine · doi:10.1159/000113648 · Cited by 214
Biedermann, D., Vavříková, E., Cvak, L., & Křen, V. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70122k · Cited by 196
SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
Sridar, C., Goosen, T. C., Kent, U. M., Williams, J. A., & Hollenberg, P. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.587 · Cited by 192
Drug–drug interactions of silymarin on the perspective of pharmacokinetics
Wu, J.-W., Lin, L.-C., & Tsai, T.-H. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.10.036 · Cited by 191
Salmi, H. A., & Sarna, S. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209182242 · Cited by 190
A systematic review on ethnomedicines of anti-cancer plants
Tariq, A., Sadia, S., Pan, K., Ullah, I., Mussarat, S., Sun, F., Abiodun, O. O., Batbaatar, A., Li, Z., Song, D., et al. (2017) · Phytotherapy Research · doi:10.1002/ptr.5751 · Cited by 189
Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data
Izzo, A. A. (2012) · Medical Principles and Practice · doi:10.1159/000334488 · Cited by 182
Self-citationWen, Z., Dumas, T. E., Schrieber, S. J., Hawke, R. L., Fried, M. W., & Smith, P. C. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017566 · Cited by 172
Principles of pharmacological research of nutraceuticals
Andrew, R., & Izzo, A. A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13779 · Cited by 170
Self-citationMetabolic aspects of adult patients with nonalcoholic fatty liver disease
Abenavoli, L., Milic, N., Di Renzo, L., Preveden, T., Medić-Stojanoska, M., & De Lorenzo, A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i31.7006 · Cited by 158
Self-citationVenkataramanan, R., Ramachandran, V., Komoroski, B. J., Zhang, S., Schiff, P. L., & Strom, S. C. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15071-4 · Cited by 156
The silymarin composition… and why does it matter???
Chambers, C. S., Holečková, V., Petrásková, L., Biedermann, D., Valentová, K., Buchta, M., & Vladimír Křen, A. (2017) · Food Research International · doi:10.1016/j.foodres.2017.07.017 · Cited by 154
Hawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347475 · Cited by 152
Abenavoli, L., Greco, M., Milic, N., Accattato, F., Foti, D., Gulletta, E., & Luzza, F. (2017) · Nutrients · doi:10.3390/nu9080870 · Cited by 144
Self-citationSilymarin impacts on immune system as an immunomodulator: One key for many locks
Esmaeil, N., Balouchi-Anaraki, S., Gharagozloo, M., & Moayedi, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.06.030 · Cited by 139
Silymarin in non alcoholic fatty liver disease
Cacciapuoti, F. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i3.109 · Cited by 134
Acute Liver Failure Caused byAmanita phalloidesPoisoning
Santi, L., Maggioli, C., Mastroroberto, M., Tufoni, M., Napoli, L., & Caraceni, P. (2012) · International Journal of Hepatology · doi:10.1155/2012/487480 · Cited by 130
Silymarin and hepatocellular carcinoma
Mastron, J. K., Siveen, K. S., Sethi, G., & Bishayee, A. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000211 · Cited by 123
Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116
Self-citationPharmacokinetic studies with silymarin in human serum and bile.
Lorenz, D., Lücker, P. W., Mennicke, W. H., & Wetzelsberger, N. (1984) · PubMed · Cited by 114
Targeting STAT3 with silibinin to improve cancer therapeutics
Bosch‐Barrera, J., Queralt, B., & Menéndez, J. A. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.06.003 · Cited by 113
Zhang, B., Xu, D., She, L., Wang, Z., Yang, N., Sun, R., Zhang, Y., Yan, C., Wei, Q., Aa, J., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700602r · Cited by 113
Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan
van Erp, N. P. H., Baker, S. D., Zhao, M., Rudek, M. A., Guchelaar, H., Nortier, J. W. R., Sparreboom, A., & Gelderblom, H. A. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1288 · Cited by 112
Gurley, B. J., Hubbard, M. A., Williams, D. K., Thaden, J. J., Tong, Y., Gentry, W. B., Breen, P. J., Carrier, D. J., & Cheboyina, S. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005284854 · Cited by 112
Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis
Lucena, M. I., Andrade, R. J., Cruz, J. P. D. L., Rodríguez-Mendizábal, M., Blanco‐Reina, E., & de la Cuesta, F. S. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40002 · Cited by 111
Zhong, S., Fan, Y., Yan, Q., Fan, X., Wu, B., Han, Y., Zhang, Y., Chen, Y., Zhang, H., & Niu, J. (2017) · Medicine · doi:10.1097/md.0000000000009061 · Cited by 111
Polachi, N., Bai, G., Li, T., Chu, Y., Wang, X., Li, S., Gu, N., Wu, J., Li, W., Zhang, Y., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.070 · Cited by 109
Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial.
Solhi, H., Ghahremani, R., Kazemifar, A. M., & Yazdi, Z. H. (2014) · Europe PMC (PubMed Central) · Cited by 107
Zhu, H., Brinda, B. J., Chavin, K. D., Bernstein, H. J., Patrick, K. S., & Markowitz, J. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052423 · Cited by 107
Clichici, S. V., Olteanu, D. E., Nagy, A.-L., Oros, A., Filip, G. A., & Mircea, P. A. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.0179 · Cited by 102
Weyhenmeyer, R., Mascher, H. J., & Birkmayer, J. G. D. (1992) · PubMed · Cited by 99
Kim, M. K., Yang, S., Kim, J. M., Lee, J., Kim, Y. S., & Lee, J. I. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1029 · Cited by 96
Natural Products as Mechanism‐based Anticancer Agents: Sp Transcription Factors as Targets
Safe, S. H., & Kasiappan, R. (2016) · Phytotherapy Research · doi:10.1002/ptr.5669 · Cited by 91
Abenavoli, L., Greco, M., Nazionale, I., Peta, V., Milić, N., Accattato, F., FOTI, D. P., Gulletta, E., & Luzza, F. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1004312 · Cited by 90
Self-citationEffects of Silymarin on Diabetes Mellitus Complications: A Review
Stolf, A. M., Cardoso, C. C., & Acco, A. (2017) · Phytotherapy Research · doi:10.1002/ptr.5768 · Cited by 90
Blaising, J., Levy, P. L., Gondeau, C., Phelip, C., Varbanov, M., Teissier, É., Ruggiero, F., Polyak, S. J., Oberlies, N. H., Ivanovic, T., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12155 · Cited by 87
Absorption and metabolism of milk thistle flavanolignans in humans
Calani, L., Brighenti, F., Bruni, R., & Rio, D. D. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.09.004 · Cited by 85
Sonnenbichler, J., Goldbero, M., Hane, L., Madubunyi, I. I., Vogl, S., & Isolde, Z. E. T. L. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90233-9 · Cited by 85
Schrieber, S. J., Wen, Z., Vourvahis, M., Smith, P. C., Fried, M. W., Kashuba, A. D. M., & Hawke, R. L. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019604 · Cited by 83
Stiuso, P., Scognamiglio, I., Murolo, M., Ferranti, P., Simone, C. D., Rizzo, M. R., Tuccillo, C., Caraglia, M., Loguercio, C., & Federico, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/169216 · Cited by 83
Acute liver injury and acute liver failure from mushroom poisoning in N orth A merica
Karvellas, C. J., Tillman, H., Leung, A. A. C., Lee, W. M., Schilsky, M. L., Hameed, B., Stravitz, R. T., McGuire, B. M., Fix, O. K., & the United States Acute Liver Failure Study Group (2016) · Liver International · doi:10.1111/liv.13080 · Cited by 81
Serviddio, G., Bellanti, F., Stanca, E., Lunetti, P., Blonda, M., Tamborra, R., Siculella, L., Vendemiale, G., Capobianco, L., & Giudetti, A. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.002 · Cited by 79
Luangchosiri, C., Thakkinstian, A., Chitphuk, S., Stitchantrakul, W., Petraksa, S., & Sobhonslidsuk, A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0861-7 · Cited by 79
Yang, G., Zhao, Y., Zhang, Y., Dang, B., Liu, Y., & Feng, N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92665 · Cited by 77
Gatti, G., & Perucca, E. (1994) · PubMed · Cited by 72
Aghazadeh, S., Amini, R., Yazdanparast, R., & Ghaffari, S. H. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.04.009 · Cited by 72
Kim, S. H., Oh, D., Oh, J. H., Son, T. G., Yuk, D. Y., & Jung, Y. (2016) · Molecules · doi:10.3390/molecules21040443 · Cited by 71
Silibinin: a potential old drug for cancer therapy
Zhu, X., Ding, Y.-H., Wu, Y. P., Qian, L.-Y., Zou, H., & He, Q. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1208563 · Cited by 69
Li, C., Hsiang, C., Wu, S., & Ho, T. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.025 · Cited by 68
Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway
Kim, E. J., Lee, M. Y., & Jeon, Y. J. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.3.211 · Cited by 64
New Therapeutic Potentials of Milk Thistle ( Silybum marianum )
Milić, N., Milošević, N., Suvajdžić, L. Đ., Žarkov, M., & Abenavoli, L. (2013) · Natural Product Communications · doi:10.1177/1934578x1300801236 · Cited by 63
Self-citationA placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease.
Hashemi, S. J., Hajiani, E., & Sardabi, E. H. (2009) · Cited by 63
Siegel, A. B., Narayan, R., Rodriguez, R., Goyal, A., Jacobson, J. S., Kelly, K. M., Ladas, E. J., Lunghofer, P. J., Hansen, R. J., Gustafson, D. L., et al. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735413490798 · Cited by 63
Schrieber, S. J., Hawke, R. L., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., Meyers, C. M., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040212 · Cited by 62
Epidemiology and Natural History of Alcoholic Liver Disease
Masarone, M., Rosato, V., Dallio, M., Abenavoli, L., Federico, A., Loguercio, C., & Persico, M. (2016) · Reviews on Recent Clinical Trials · doi:10.2174/1574887111666160810101202 · Cited by 61
Self-citation[Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
Trinchet, J., Coste, T. C., Vg, L., et al. (1989) · PubMed · Cited by 60
The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity
Kawaguchi‐Suzuki, M., Frye, R. F., Zhu, H., Brinda, B. J., Chavin, K. D., Bernstein, H. J., & Markowitz, J. S. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057232 · Cited by 60
Sokar, S. S., El‐Sayad, M. E., Ghoneim, M. E.-S., & Shebl, A. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.010 · Cited by 58
Spatial organization of silybin biosynthesis in milk thistle [Silybum marianum (L.) Gaertn]
Lv, Y., Gao, S., Xu, S., Du, G., Zhou, J., & Chen, J. (2017) · The Plant Journal · doi:10.1111/tpj.13736 · Cited by 53
Highly bioavailable silibinin nanoparticles inhibit HCV infection
Liu, C., Lin, C., Hsu, W.-C., Chung, C.-Y., Lin, C., Jassey, A., Chang, S.-P., Tai, C., Tai, C.-J., Shields, J. A., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312019 · Cited by 52
Kang, J. S., Park, S., Yang, K., & Kim, H. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00827-5 · Cited by 50
Zhang, S., Pan, H., Peng, X., Lu, H., Fan, H., Zheng, X., Xu, G., Wang, M., & Wang, J. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13070 · Cited by 48
Gu, H. R., Park, S. C., Choi, S. J., Lee, J. C., Kim, Y. C., Han, C. J., Kim, J., Yang, K. Y., Kim, Y. J., Noh, G. Y., et al. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.1.49 · Cited by 47
Dietary supplementation in patients with alcoholic liver disease: a review on current evidence
Ghorbani, Z., Hajizadeh, M., & Hekmatdoost, A. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60096-6 · Cited by 46
Vailati, A., Aristia, L., Sozzé, E., Milani, F., Inglese, V., GALENDA, P., Bossolo, P. A., Ascari, E., Lampertico, M., Comis, S., et al. (1993) · Fitoterapia · Cited by 46
Marin, V., Gazzin, S., Gambaro, S. E., Ben, M. D., Calligaris, S., Anese, M., Raseni, A., Avellini, C., Giraudi, P. J., Tiribelli, C., et al. (2017) · Nutrients · doi:10.3390/nu9091006 · Cited by 46
Gharagozloo, M., Jafari, S., Esmaeil, N., Javid, E. N., Bagherpour, B., & Rezaei, A. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12088 · Cited by 45
Yang, Z., Zhuang, L., Lu, Y., Xu, Q., & Chen, X. (2014) · BioMed Research International · doi:10.1155/2014/941085 · Cited by 44
Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease
Allain, H., Schück, S., Lebreton, S., Strenge-Hesse, A., Braun, W. H., Gandon, J. M., & Brissot, P. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017117 · Cited by 40
Jančová, P., Šiller, M., Anzenbacherová, E., Křen, V., Anzenbacher, P., & Šimánek, V. (2011) · Xenobiotica · doi:10.3109/00498254.2011.573017 · Cited by 39
Mohammadi, A. A. H., Amir, Z., & Rafiei, R. (2008) · Hepatitis Monthly · Cited by 37
Chen, S., Qiu, H.-C., Hu, Y., Wang, Y., & Wang, Y. (2016) · Phytotherapy Research · doi:10.1002/ptr.5594 · Cited by 37
Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning
Trakulsrichai, S., Sriapha, C., Tongpoo, A., Udomsubpayakul, U., Wongvisawakorn, S., Srisuma, S., & Wananukul, W. (2017) · International Journal of General Medicine · doi:10.2147/ijgm.s141111 · Cited by 37
Ramanathan, R., & Karthikeyan, S. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.07.014 · Cited by 35
Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
Abenavoli, L., & Bellentani, S. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.842893 · Cited by 34
Self-citationA Mini Review on the Chemistry and Neuroprotective Effects of Silymarin
Devi, K. P., Malar, D. S., Braidy, N., Nabavi, S. M., & Nabavi, S. F. (2017) · Current Drug Targets · doi:10.2174/1389450117666161227125121 · Cited by 34
Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice
Milosevic, N. P., Milanović, M., Abenavoli, L., & Milić, N. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216110337 · Cited by 31
Self-citationMeta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B
Wei, F., Liu, S.-K., Liu, X.-Y., Li, Z.-J., Li, B., Zhou, Y., Zhang, H.-Y., & Li, Y.-W. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1789-1 · Cited by 29
Albassam, A. A., Frye, R. F., & Markowitz, J. S. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.025 · Cited by 29
Evaluating the Safety and Efficacy of Silymarin in β -Thalassemia Patients: A Review
Esfahani, B. A.-S. M., Reisi, N., & Mirmoghtadaei, M. (2015) · Hemoglobin · doi:10.3109/03630269.2014.1003224 · Cited by 25
Protective effect of silymarin during coronary artery bypass grafting surgery.
Altaei, T. S. (2012) · Europe PMC (PubMed Central) · Cited by 22
Darvishi‐Khezri, H., Salehifar, E., Kosaryan, M., Karami, H., Mahdavi, M., Alipour, A., & Aliasgharian, A. (2017) · Phytotherapy Research · doi:10.1002/ptr.5995 · Cited by 22
Bae, K., Park, J.-H., Kim, J., Cho, C.-K., Oh, B., Costa, D. S. J., Lim, S. H.-S., Deng, G. E., & Yoo, H.-S. (2017) · Phytotherapy Research · doi:10.1002/ptr.5781 · Cited by 20
Li, W., Yu, G., Hogan, R. M., Mohandas, R., Frye, R. F., Gumpricht, E., & Markowitz, J. S. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.11.013 · Cited by 20
Pais, P., & D’Amato, M. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0068-2 · Cited by 19
Yormaz, S., Bülbüloğlu, E., Kurutaş, E. B., Ciralik, H., Yuzbasioglu, M. F., Yildiz, H., Çoşkuner, İ., Sılay, E., Kantarçeken, B., Göksu, M., et al. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_035 · Cited by 16
Cited by
The Therapeutic Potential of Apigenin
Salehi, B., Venditti, A., Sharifi-Rad, M., Kręgiel, D., Sharifi-Rad, J., Durazzo, A., Lucarini, M., Santini, A., Souto, E. B., Novellino, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061305 · Cited by 1,238
Self-citationPolyphenols: A concise overview on the chemistry, occurrence, and human health
Durazzo, A., Lucarini, M., Souto, E. B., Cicala, C., Caiazzo, E., Izzo, A. A., Novellino, E., & Santini, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6419 · Cited by 802
Self-citationAntidiabetic Potential of Medicinal Plants and Their Active Components
Salehi, B., Ata, A., V. Anil Kumar, N., Sharopov, F., Ramírez-Alarcón, K., Ruiz-Ortega, A., Abdulmajid Ayatollahi, S., Valere Tsouh Fokou, P., Kobarfard, F., Amiruddin Zakaria, Z., et al. (2019) · Biomolecules · doi:10.3390/biom9100551 · Cited by 747
Self-citationSaha, P., Talukdar, A. D., Nath, R., Sarker, S. D., Nahar, L., Sahu, J., & Choudhury, M. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00509 · Cited by 148
Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020146 · Cited by 144
Self-citation
Metadata
- Authors
- Abenavoli, L., Izzo, A. A., Milić, N., Cicala, C., Santini, A., & Capasso, R.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2018-08-06
- Volume
- 32
- Issue
- 11
- Pages
- 2202-2213
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2886246189
- Cited by
- 463
- References
- 107
- FWCI
- 24.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.